3 stocks, including PolyNovo, impress shareholders with strong sales updates
Nick Sundich, January 16, 2023
Several ASX companies released trading updates this morning and some of them left investors particularly impressed, specifically Tyro Payments (ASX:TYR), PolyNovo (ASX:PNV) and Super Retail Group (ASX:SUL).
No time to do stock research, but you still want to invest?
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!
GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY
The good trading update from Tyro
Tyro Payments (ASX:TYR), a company that provides EFTPOS terminals, provided a trading update for its unaudited results for the first half of FY23 and gave updated guidance for the full year. In 1HY23 it recorded $21.7bn in transaction value, $216.6m in revenue and a $102.8m statutory gross profit – all of which were 35-45% higher than the year before. EBITDA was $19.5m, up 601% from 12 months earlier.
For the full year, Tyro expects to record $37-$41m EBITDA (up from just $10.7m in FY22). It also reported that it is on track to achieve positive free cash flow during FY23. The shares rose more than 7% this morning.
PolyNovo sales jump to record level
Medtech company PolyNovo (ASX:PNV) also reported unaudited 1HY23 results, achieving $27.3m in sales, a figure that was up 68% from 12 months ago and a record for PolyNovo. $22.8m of this was achieved in the US, while the balance was from the rest of the world. Although non-US sales grew stronger because of the introduction of new markets, US sales still grew by 61%.
After PolyNovo’s massive rally since April 2022, the shares didn’t move too much on this morning’s news.
Lastly, retail conglomerate Super Retail Group (ASX:SUL) recorded ~$2bn in unaudited sales, along with a $212-$218m pre-tax profit. The shares jumped more than 8% this morning.
The bad trading update: Baby Bunting
Baby Bunting, meanwhile, has not been able to take a trick in recent months. Three months ago, shares fell 25% after a trading update where it reported margin pressure. This was not just because of rising costs, but also because of the company’s decision not to follow its competitors in discounting top selling items.
Today Baby Bunting revealed that its 1HY23 NPAT fell 59% from $12.5m to $5.1m. This occurred despite the company recording sales growth of 6.6% from $239.1m to $254.9m. Needless to say, the shares took another hit and fell by more than 11%.
No time to do stock research, but you still want to invest?
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!
GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY
No credit card needed and the trial expires automatically.
Blog Categories
Get Our Top 5 ASX Stocks for FY25
Recent Posts
Here’s how to analyse REITs: The 5 most important things investors need to look out for
In this article, we outline how to analyse REITs (Real Estate Investment Trusts). Despite trading no different to other listed entities,…
PainChek (ASX:PCK): Will 2025 be the year it finally makes progress and enters the US market?
PainChek (ASX:PCK) has among the most admirable medical technologies there is, in the form of an app that can detect…
Tesla’s Earnings Surprise: What Does a 26% Stock Surge Mean for the Future?
Cybercab and Robovan are here to offer an exhilarating experience into the world of Tesla’s innovations. Recently, Tesla unveiled their…